STRASS2
Phase 3 Recruiting
250 enrolled
ARCH
Phase 3 Recruiting
390 enrolled
ADOPT-lung
Phase 3 Recruiting
290 enrolled
STOP-GAP
Phase 3 Recruiting
614 enrolled
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Phase 3 Recruiting
196 enrolled
BATTMAN
Phase 3 Recruiting
834 enrolled
ATOM
Phase 3 Recruiting
290 enrolled
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 Recruiting
288 enrolled
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 Recruiting
804 enrolled
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 Recruiting
1,450 enrolled
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Phase 3 Recruiting
408 enrolled
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 Recruiting
264 enrolled
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Phase 3 Recruiting
1,780 enrolled
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Phase 3 Recruiting
750 enrolled
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 Recruiting
62 enrolled
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Phase 3 Recruiting
1,186 enrolled
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Phase 3 Recruiting
205 enrolled
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Phase 3 Recruiting
225 enrolled
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Phase 3 Recruiting
105 enrolled
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Phase 3 Recruiting
60 enrolled
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Phase 3 Recruiting
110 enrolled
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Phase 3 Recruiting
94 enrolled
MajesTEC-4
Phase 3 Recruiting
1,594 enrolled
LEGATO
Phase 3 Recruiting
411 enrolled
VIGOR
Phase 3 Recruiting
468 enrolled
OPTION-DDR
Phase 3 Recruiting
236 enrolled
PROLoNg
Phase 3 Recruiting
200 enrolled
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Phase 3 Recruiting
1,000 enrolled
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Phase 3 Recruiting
528 enrolled
IMCOMG
Phase 3 Recruiting
128 enrolled
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Phase 3 Recruiting
230 enrolled
TRIPLE-SWITCH
Phase 3 Recruiting
830 enrolled
TAILOR RT
Phase 3 Recruiting
2,140 enrolled
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Phase 3 Recruiting
206 enrolled
SELECT
Phase 3 Recruiting
510 enrolled
NEO-RT
Phase 3 Recruiting
250 enrolled
ASCENDE-SBRT
Phase 3 Recruiting
710 enrolled
HOTT
Phase 3 Recruiting
220 enrolled
USZ-STRIKE
Phase 3 Recruiting
180 enrolled
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Phase 3 Recruiting
274 enrolled
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Phase 3 Recruiting
1,057 enrolled
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Phase 3 Recruiting
2,400 enrolled
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Phase 3 Recruiting
491 enrolled
MATAO
Phase 3 Recruiting
540 enrolled
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3 Recruiting
1,600 enrolled
PROBE
Phase 3 Recruiting
364 enrolled
COMPRO
Phase 3 Recruiting
276 enrolled
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Phase 3 Recruiting
192 enrolled
TREAT ctDNA
Phase 3 Recruiting
220 enrolled
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Phase 3 Recruiting
510 enrolled